TY - JOUR
T1 - Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations under hypoxic conditions
AU - Osada-Oka, Mayuko
AU - Kuwamura, Hikaru
AU - Imamiya, Risa
AU - Kobayashi, Keiko
AU - Minamiyama, Yukiko
AU - Takahashi, Katsuyuki
AU - Tanaka, Masako
AU - Shiota, Masayuki
N1 - Funding Information:
This work is supported by JSPS KAKENHI (Grant Number; JP 17K08836 , Japan).
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/4/5
Y1 - 2022/4/5
N2 - Hypoxia-inducible factor-1α (HIF-1α) and p53 are involved in anticancer drug resistance under hypoxic conditions. Here, we found that the cytotoxicity of anticancer drugs (doxorubicin, gemcitabine, and cisplatin) was lower at 1% O2 than at 5% O2. We examined the effects of these drugs on HIF-1α and p53 expression under different hypoxic oxygen concentrations. At 5% O2, the drugs decreased HIF-1α expression and increased p53 levels. At 1% O2, the drugs increased HIF-1α expression but did not alter p53 levels. When the HIF-1α protein was stabilized by DMOG under normoxic conditions, doxorubicin did not increase the level of p53 expression. These results show that the maintenance of HIF-1α expression blocked doxorubicin-dependent increases in p53 expression. We hypothesized the mechanism of HIF-1α protein translation might be different between at 5% and at 1% O2, because many reports indicate that the same mechanism of HIF-1α protein stabilization occurs under hypoxic conditions, such as 5% and 1% O2. The level of phosphorylated-4E-BP1, which causes translation of HIF-1α, was higher at 1% O2 than at 5% O2. Our results suggest that the sensitivity of tumor cells to anticancer drugs is dependent oxygen concentrations under hypoxic conditions, and involves 4E-BP1-dependent stabilization of the HIF-1α protein.
AB - Hypoxia-inducible factor-1α (HIF-1α) and p53 are involved in anticancer drug resistance under hypoxic conditions. Here, we found that the cytotoxicity of anticancer drugs (doxorubicin, gemcitabine, and cisplatin) was lower at 1% O2 than at 5% O2. We examined the effects of these drugs on HIF-1α and p53 expression under different hypoxic oxygen concentrations. At 5% O2, the drugs decreased HIF-1α expression and increased p53 levels. At 1% O2, the drugs increased HIF-1α expression but did not alter p53 levels. When the HIF-1α protein was stabilized by DMOG under normoxic conditions, doxorubicin did not increase the level of p53 expression. These results show that the maintenance of HIF-1α expression blocked doxorubicin-dependent increases in p53 expression. We hypothesized the mechanism of HIF-1α protein translation might be different between at 5% and at 1% O2, because many reports indicate that the same mechanism of HIF-1α protein stabilization occurs under hypoxic conditions, such as 5% and 1% O2. The level of phosphorylated-4E-BP1, which causes translation of HIF-1α, was higher at 1% O2 than at 5% O2. Our results suggest that the sensitivity of tumor cells to anticancer drugs is dependent oxygen concentrations under hypoxic conditions, and involves 4E-BP1-dependent stabilization of the HIF-1α protein.
KW - Anticancer drug resistance
KW - Eukaryotic initiation factor 4E-binding protein 1
KW - Hypoxia-inducible factor-1alpha
KW - p53
UR - http://www.scopus.com/inward/record.url?scp=85125129131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125129131&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2022.174845
DO - 10.1016/j.ejphar.2022.174845
M3 - Article
C2 - 35202675
AN - SCOPUS:85125129131
SN - 0014-2999
VL - 920
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
M1 - 174845
ER -